Blood Pressure Medication Valsartan Recalled Over Dissolution Concerns
Novartis has issued a Class II recall for a batch of its valsartan blood pressure drug, Diovan, because it failed dissolution tests. This issue could reduce the drug's effectiveness, potentially causing temporary or reversible health consequences for patients. Individuals taking this medication should consult their physician.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.
Open NewsSnap.ai